Skip to main content
. 2024 Mar 16;13(6):e031732. doi: 10.1161/JAHA.123.031732

Figure 3. Associations of genetically determined iron markers with coronary artery disease, heart failure, ischemic stroke, and type 2 diabetes.

Figure 3

Odds ratios represent the estimates for the effect of a 1‐SD increase in levels of transferrin saturation, serum iron, log‐transformed serum ferritin, and total iron binding capacity, respectively, on disease outcomes.